Kosaka et al. reported that TRIM29 upregulation was associated with worse clinical outcomes, such as extent of tumor invasion, lymph node metastasis, larger tumor size, and poorer histological grade in GC patients (27). Here, TRIM29 is linked to gastric cancer.